TD52

Biochem/physiol Actions

TD52, an erlotinib analog, is a putative inhibitor of CIP2A that exhibits potent antitumor efficacy on HCC and TNBC cells. TD52 induces apoptosis through downregulation of CIP2A (Cancerous inhibitor of protein phosphatase 2A) in HCC, NSCLC and TNBC cells. Apparently TD52 indirectly downregulates CIP2A transcripts through interrupting the binding of Elk1 to CIP2A promoter. TD52 is a weak inhibitor of EGFR tyrosine kinase.

No detailed specifications are available for this product.

There are no downloads for this product.

Code Description Colour Manufacturer Storage Temp. Solubility Form Assay Price Quantity
3575870 TD52 white to beige SIGMA-ALDRICH 2-8°C DMSO: 2 mg/mL, clear
£402.54 (exc VAT) per 25MG
-
+
3575871 TD52 white to beige SIGMA-ALDRICH 2-8°C DMSO: 2 mg/mL, clear
£106.00 (exc VAT) per 5MG
-
+